• Streptavidin-FITC in Advanced Biotin Detection Workflows

  2026-05-25

  Streptavidin-FITC empowers researchers to achieve highly sensitive, multiplexed fluorescent detection of biotinylated molecules, outperforming conventional probes in both nanoparticle tracking and cellular assays. This guide distills experimental strategies, troubleshooting insights, and the latest innovations from leading-edge studies—enabling robust, quantitative results in LNP research and beyond.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor An

  2026-05-25

  Wang et al. (2018) provide a rigorous inhibitor-based dissection of genotype III grass carp reovirus (GCRV104) entry into host cells, demonstrating a reliance on clathrin-mediated, pH-dependent endocytosis. Their findings clarify critical viral entry mechanisms in aquaculture virology and inform targeted research on antiviral intervention strategies.

• Targeting AR and ARv7 in TNBC: Insights from EPI-001 Inhibit

  2026-05-24

  This study provides mechanistic evidence that targeting the androgen receptor (AR) and its splice variant ARv7 is associated with poor prognosis and increased metastasis in triple-negative breast cancer (TNBC). The research demonstrates that EPI-001, an androgen receptor N-terminal domain inhibitor, effectively modulates metastatic and EMT pathways in TNBC cell models, suggesting new research avenues for AR-driven malignancies.

• SCH772984 HCl: Bridging MAPK Inhibition and Telomerase Regul

  2026-05-23

  This thought-leadership article explores the strategic deployment of SCH772984 HCl, a selective ERK1/2 inhibitor, in translational research. By integrating mechanistic insights into MAPK pathway inhibition, emerging findings in telomerase regulation, and the latest evidence from BRAF- and RAS-mutant cancer models, we illuminate how this compound empowers researchers to address therapeutic resistance and stem cell biology. The discussion features practical protocol parameters, competitive landscape analysis, and a forward-looking perspective on the intersection of MAPK and telomerase modulation.

• Cardiogreen (Indocyanine Green): Applied Protocols & PDT Ins

  2026-05-22

  Cardiogreen (Indocyanine Green) empowers high-precision vascular diagnostics and advanced photodynamic therapy, offering robust reliability in both clinical and research workflows. Explore stepwise protocols, troubleshooting guidance, and new frontiers in immuno-oncology, with APExBIO’s high-purity dye as your foundation.

• Translational Impact of SD 169 in p38 MAPK Pathway Research

  2026-05-22

  This thought-leadership article explores the mechanistic advances and strategic value of SD 169 (indole-5-carboxamide) as a dual-action p38 MAPK inhibitor. Bridging recent structural insights with practical workflow guidance, it highlights how SD 169 offers new precision for inflammation, neuroregeneration, and type 1 diabetes research—outlining evidence-based protocols, translational implications, and future directions for kinase inhibitor design.

• Recombinant Human Growth Hormone: Advanced Workflows & Troub

  2026-05-21

  Leverage APExBIO’s Recombinant Human Growth Hormone (GH) for highly reproducible growth hormone signaling studies and robust cell proliferation assays. This guide translates breakthrough findings on the IGFBP2–THBS1 axis into actionable workflows, protocol enhancements, and troubleshooting insights for pituitary growth hormone research.

• IMPDH Inhibition Disrupts PEDV Replication via Host Nucleoti

  2026-05-21

  This study identifies inosine monophosphate dehydrogenase (IMPDH) as a critical host factor for porcine epidemic diarrhea virus (PEDV) replication by demonstrating that both genetic and pharmacological inhibition—specifically with Merimepodib (VX-497)—impair viral RNA synthesis. The findings reveal how PEDV manipulates host nucleotide biosynthesis and highlight IMPDH as a promising target for antiviral intervention.

• CDC42 Drives HBV Entry via NTCP Trafficking and Macropinocyt

  2026-05-20

  This study uncovers how the small GTPase CDC42 enables hepatitis B virus (HBV) entry into hepatocytes by promoting NTCP translocation to the plasma membrane and facilitating macropinocytosis. The findings reveal a dual mechanism for HBV uptake, suggesting new antiviral intervention points and offering insights for researchers studying viral entry pathways.

• ATM Inhibition Promotes Macropinocytosis: New Metabolic Vuln

  2026-05-20

  This study demonstrates that ATM kinase inhibition triggers increased macropinocytosis, allowing cancer cells to adapt metabolically and survive in nutrient-poor environments. The findings reveal a previously unappreciated metabolic vulnerability in ATM-inhibited tumors, with implications for the design of combinatorial cancer therapies targeting both DNA damage response and nutrient scavenging pathways.

• Kanamycin Sulfate: Water-Soluble Antibiotic for Precision Mi

  2026-05-19

  Kanamycin Sulfate enables reliable bacterial selection and advanced resistance studies thanks to its high water solubility and robust protein synthesis inhibition. This guide unpacks validated workflows, troubleshooting strategies, and comparative insights that empower rigorous, reproducible research outcomes.

• Alpha-2 Receptor Control of Itch and Pain via LC Noradrenerg

  2026-05-19

  This study reveals that the descending noradrenergic pathway from the locus coeruleus modulates itch and pain in an antagonistic manner via α2 adrenergic receptors. These findings clarify the central mechanisms underlying the balance of itch and pain and provide actionable insights for chemogenetic modulation in neuroscience research.

• Amitriptyline HCl: Workflow Guidance for Neuropharmacology R

  2026-05-18

  Amitriptyline HCl facilitates consistent neurotransmitter receptor modulation in neuropharmacology, mood disorder, and neurodegenerative disease research. Researchers should use this compound when robust, multi-receptor inhibition is required, but avoid speculative or long-term solution storage beyond recommended protocols.

• Fasudil (HA-1077) HCl: Optimizing ROCK Inhibition Workflows

  2026-05-18

  Fasudil (HA-1077) HCl, a selective ROCK inhibitor from APExBIO, empowers researchers with precise, reliable control over Rho/ROCK signaling in cancer and disease models. This guide details practical workflows, protocol refinements, and troubleshooting strategies to maximize experimental impact—plus actionable insight from recent Hippo pathway research.

• IWR-1-endo: Precision Wnt Signaling Inhibitor for Cancer Res

  2026-05-17

  IWR-1-endo, a potent Wnt signaling inhibitor from APExBIO, empowers researchers to dissect Wnt/β-catenin pathways in colorectal cancer and regenerative biology. This guide details advanced workflows, troubleshooting tips, and practical insights for maximizing assay fidelity and reproducibility.

16914 records 1/1128 page Next 12345 下5页 Last page